18.0 billion

Gross loans: SEK 18.0 billion, up 19 per cent year-on-year²

27.7%

Cost/income ratio, excluding one-offs, vs 25.8% in Q2 2025, temporarily elevated by preparations for the MedMera integration²

0.31

Earnings per share: SEK 0.31, vs SEK 0.27 in Q2 2025²

16.3%

Return on target equity (ROTE): 16.3%, vs 12.2% in Q2 2025² ⁴
Pure-play Nordic consumer finance
Proven platform scalability - 42% EPS CAGR 2022-2025
Swedish-domiciled, listed on Nasdaq Stockholm
Accretive MedMera acquisition – loan book +~65%
Ambition to more than double EPS from 2025 to 2028
>10% annual loan growth Targeting a loan book of SEK ~23bn
Increased efficiency Cost/income ratio of ~22%
Reduced loan lossesLoan loss ratio of ~4%

Press releases

Events (Calendar)

Latest news

A nicely dressed man with a bike. It is Autumn.

Morrow Bank advances MedMera integration with strategic divestment

Morrow Bank has agreed to divest non-core parts of MedMera’s operations to a leading global credit investment firm. The share sale is priced at an approximately SEK 90 million premium above equity value at completion.

Q2 and H1 2026 Results

Continued organic earnings growth and MedMera Bank acquisition completed.

Stockholm skyline in springtime with spring flowers in the foreground. picture.

Q1 Results 2026

Announced largest acquisition to date – accelerating profitability.